[ad_1]

UK researchers announced a breakthrough gene therapy that slowed Huntington’s disease for the first time. Early-stage trials at University College London showed some patients’ condition progressed 75% slower over three years. The therapy, AMT-130, is delivered via direct brain injection.
[ad_2]
Source link
France lets US planes use its bases for non-combat missions in Iran
France on Thursday confirmed it had temporarily allowed the US Air Force to use one of its bases for missions...



